INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Instituto Mexicano del Seguro Social
Ciudad de México, MéxicoPublicaciones en colaboración con investigadores/as de Instituto Mexicano del Seguro Social (12)
2023
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study
European Respiratory Journal, Vol. 60, Núm. 3
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality
Heart, Vol. 107, Núm. 6, pp. 497-502
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
-
Two New Dihydrosphingosine Analogs Against Mycobacterium tuberculosis Affect gltA1, lprQ, and rpsO Expression
Frontiers in Microbiology, Vol. 12
2016
-
Efficacious In Vitro and In Vivo Effects of Dihydrosphingosine–Ethambutol Analogues Against Susceptible and Multi-drug-resistant Mycobacterium tuberculosis
Archives of Medical Research, Vol. 47, Núm. 4, pp. 262-270
2009
-
Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis
Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 19, pp. 5764-5768
2007
-
[1,3]Diazaheterofused isoindolol derivatives displaying anxiolytic-like effects on mice
Bioorganic and Medicinal Chemistry Letters, Vol. 17, Núm. 14, pp. 4016-4021
2005
-
Anxiolytic effects of benzalphthalides
Bioorganic and Medicinal Chemistry Letters, Vol. 15, Núm. 15, pp. 3483-3486